A detailed history of Geode Capital Management, LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Geode Capital Management, LLC holds 36,236 shares of IFRX stock, worth $81,168. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,236
Previous 36,236 -0.0%
Holding current value
$81,168
Previous $63,000 12.7%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$2.66 - $4.33 $13,145 - $21,398
4,942 Added 15.79%
36,236 $107,000
Q2 2023

Aug 11, 2023

BUY
$2.05 - $6.1 $10,182 - $30,298
4,967 Added 18.87%
31,294 $139,000
Q1 2022

May 13, 2022

BUY
$1.83 - $4.48 $13,424 - $32,865
7,336 Added 38.63%
26,327 $48,000
Q3 2021

Nov 12, 2021

BUY
$2.25 - $3.03 $42,729 - $57,542
18,991 New
18,991 $49,000
Q4 2020

Feb 12, 2021

SELL
$3.82 - $5.32 $55,451 - $77,225
-14,516 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$3.7 - $5.47 $65,075 - $96,206
-17,588 Reduced 54.78%
14,516 $61,000
Q2 2020

Aug 13, 2020

SELL
$4.59 - $8.96 $267,776 - $522,717
-58,339 Reduced 64.5%
32,104 $147,000
Q1 2020

May 14, 2020

BUY
$2.65 - $6.08 $7,059 - $16,197
2,664 Added 3.03%
90,443 $345,000
Q4 2019

Feb 13, 2020

BUY
$2.2 - $4.54 $161,178 - $332,614
73,263 Added 504.71%
87,779 $347,000
Q2 2019

Aug 14, 2019

BUY
$3.06 - $51.61 $3,558 - $60,022
1,163 Added 8.71%
14,516 $45,000
Q1 2019

May 14, 2019

BUY
$31.16 - $48.62 $206,590 - $322,350
6,630 Added 98.62%
13,353 $504,000
Q4 2018

Feb 13, 2019

SELL
$23.33 - $36.37 $1.71 Million - $2.67 Million
-73,504 Reduced 91.62%
6,723 $244,000
Q3 2018

Nov 13, 2018

BUY
$29.34 - $35.0 $1.25 Million - $1.49 Million
42,599 Added 113.21%
80,227 $2.75 Million
Q2 2018

Aug 14, 2018

BUY
$27.33 - $41.46 $35,610 - $54,022
1,303 Added 3.59%
37,628 $1.21 Million
Q1 2018

May 15, 2018

BUY
$20.21 - $32.0 $734,128 - $1.16 Million
36,325 New
36,325 $1.05 Million

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.